Persistence in humans of antibody to subtypes of Venezuelan equine encephalomyelitis (VEE) virus after immunization with attenuated (TC-83) VEE virus vaccine.
about
Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5'-noncoding region and the E2 envelope glycoproteinIRES-dependent replication of Venezuelan equine encephalitis virus makes it highly attenuated and incapable of replicating in mosquito cellsRecombinant vaccinia virus/Venezuelan equine encephalitis (VEE) virus protects mice from peripheral VEE virus challengeEnzyme-linked immunosorbent assay detection of immunoglobulins G and M to Venezuelan equine encephalomyelitis virus in vaccinated and naturally infected humansProtective efficacies of live attenuated and formaldehyde-inactivated Venezuelan equine encephalitis virus vaccines against aerosol challenge in hamstersNeutralizing antibody responses of humans and mice to vaccination with Venezuelan encephalitis (TC-83) virusA multisystem approach for development and evaluation of inactivated vaccines for Venezuelan equine encephalitis virus (VEEV)Comparison of the immunological responses and efficacy of gamma-irradiated V3526 vaccine formulations against subcutaneous and aerosol challenge with Venezuelan equine encephalitis virus subtype IABAntibodies for biodefenseEvaluation of formalin inactivated V3526 virus with adjuvant as a next generation vaccine candidate for Venezuelan equine encephalitis virusUndiagnosed acute viral febrile illnesses, Sierra Leone.Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN/VEE viruses.IRES-driven expression of the capsid protein of the Venezuelan equine encephalitis virus TC-83 vaccine strain increases its attenuation and safetyIRES-Containing VEEV Vaccine Protects Cynomolgus Macaques from IE Venezuelan Equine Encephalitis Virus Aerosol ChallengeRecombinant sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic.A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge.Venezuelan equine encephalitis virus infection of spiny rats.Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector.Analysis of Venezuelan equine encephalitis virus capsid protein function in the inhibition of cellular transcriptionIRES-based Venezuelan equine encephalitis vaccine candidate elicits protective immunity in mice.Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primates.Alphavirus replicon vaccines.Self-replicating alphavirus RNA vaccines.Pseudoinfectious Venezuelan equine encephalitis virus: a new means of alphavirus attenuation.Venezuelan equine encephalitis virus capsid protein inhibits nuclear import in Mammalian but not in mosquito cellsThe amino-terminal domain of alphavirus capsid protein is dispensable for viral particle assembly but regulates RNA encapsidation through cooperative functions of its subdomains.
P2860
Q27486021-D0687C4A-6E70-4515-89B8-02561C55C4BFQ27486518-C608F77A-3A54-44FE-B6B9-433B6547EA5DQ27486835-FD24FD29-609E-4D61-9504-091B64962145Q27488273-DD6E6844-5E1A-4D0A-9FFF-6F483B3B079AQ27488907-4A40929E-7610-4767-ADA4-2B28EDB25F20Q27489400-06236B9C-1B2F-4283-AABE-91A2437FD261Q27490876-77C4DC0F-EFD9-405D-A44C-F12D8F8F955CQ27490878-5E9F9613-B0D0-4A1E-BAEC-D936EEBE7878Q28394941-C0333CDE-E58A-4A09-BBEE-528ED2A13BCCQ33803787-0504835D-9C7D-414C-B994-0E773162EEF3Q33816394-A67FB478-964B-4FAD-949A-0EC1770E3458Q34434918-1ED7AED3-7C5C-4522-A952-95F549C4D3E2Q34723422-92A7CA94-D354-464E-B4CD-51544913452BQ35644626-543602CC-D282-4786-B7CF-42B4F6528FBFQ35802862-F64462DF-F201-410D-881C-B257230874B5Q35861566-DF4C9E1A-509F-4145-9D70-A3B0329B977EQ35873066-D3E87C44-E838-4F05-AD9E-3B91E83A4DB7Q35881081-B921FB08-39F3-4399-8119-6CBE510D74D9Q36315076-A85931D9-4D8B-441F-934B-11399D924843Q37156478-F83B1197-D24D-46F6-953F-78055B8D0D7BQ37461110-174AD9BB-A58F-408D-8C87-B0EF28149FBFQ37995803-6805BB0B-6FC7-4CBF-9267-F298EDF7A48FQ38255634-48A93C5F-DCCA-451E-A729-A3A4F98EDA5DQ39230468-F98BE77C-4B3A-46B4-87BC-BBC6D99F1E54Q40015798-1F34622F-3028-46D9-972D-6EBBEC87AECCQ42272083-DE9950DA-D9CA-4E2E-8543-0F5394592DF7
P2860
Persistence in humans of antibody to subtypes of Venezuelan equine encephalomyelitis (VEE) virus after immunization with attenuated (TC-83) VEE virus vaccine.
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年学术文章
@wuu
1977年学术文章
@zh-cn
1977年学术文章
@zh-hans
1977年学术文章
@zh-my
1977年学术文章
@zh-sg
1977年學術文章
@yue
1977年學術文章
@zh
1977年學術文章
@zh-hant
name
Persistence in humans of antib ...... ted (TC-83) VEE virus vaccine.
@en
Persistence in humans of antibody to subtypes of Venezuelan equine encephalomyelitis
@nl
type
label
Persistence in humans of antib ...... ted (TC-83) VEE virus vaccine.
@en
Persistence in humans of antibody to subtypes of Venezuelan equine encephalomyelitis
@nl
prefLabel
Persistence in humans of antib ...... ted (TC-83) VEE virus vaccine.
@en
Persistence in humans of antibody to subtypes of Venezuelan equine encephalomyelitis
@nl
P2093
P921
P356
P1476
Persistence in humans of antib ...... ted (TC-83) VEE virus vaccine.
@en
P2093
P304
P356
10.1093/INFDIS/136.3.354
P407
P577
1977-09-01T00:00:00Z